BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27838412)

  • 1. Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model.
    Abu Lila AS; Moriyoshi N; Fukushima M; Huang CL; Wada H; Ishida T
    Cancer Lett; 2017 Aug; 400():223-231. PubMed ID: 27838412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
    Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
    Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy of metronomic S-1 dosing with oxaliplatin-containing polyethylene glycol-coated liposome improves antitumor activity in a murine colorectal tumor model.
    Doi Y; Okada T; Matsumoto H; Ichihara M; Ishida T; Kiwada H
    Cancer Sci; 2010 Nov; 101(11):2470-5. PubMed ID: 20731663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?
    Abu Lila AS; Okada T; Doi Y; Ichihara M; Ishida T; Kiwada H
    Int J Pharm; 2012 Apr; 426(1-2):263-270. PubMed ID: 22310465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer.
    Ide H; Kikuchi E; Hasegawa M; Hattori S; Yasumizu Y; Miyajima A; Oya M
    Cancer Med; 2013 Aug; 2(4):488-95. PubMed ID: 24156021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA.
    Nakamura K; Abu Lila AS; Matsunaga M; Doi Y; Ishida T; Kiwada H
    Mol Ther; 2011 Nov; 19(11):2040-7. PubMed ID: 21878904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin enhances the chemotherapeutic efficacy of S-1 against bile duct cancer: E2F-1/TS downregulation might be the mechanism.
    Cai JP; Chen W; Hou X; Liang LJ; Hao XY; Yin XY
    Anticancer Drugs; 2013 Nov; 24(10):1020-9. PubMed ID: 23941814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells.
    Ferdous T; Harada K; Kin T; Harada T; Ueyama Y
    Int J Oncol; 2013 Jul; 43(1):271-9. PubMed ID: 23695365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
    Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
    Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemically Administered RNAi Molecule Sensitizes Malignant Pleural Mesotheliomal Cells to Pemetrexed Therapy.
    Abu Lila AS; Fukushima M; Huang CL; Wada H; Ishida T
    Mol Pharm; 2016 Nov; 13(11):3955-3963. PubMed ID: 27740765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU.
    Nakata E; Fukushima M; Takai Y; Nemoto K; Ogawa Y; Nomiya T; Nakamura Y; Milas L; Yamada S
    Oncol Rep; 2006 Sep; 16(3):465-71. PubMed ID: 16865244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
    Fukushima M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan overcomes the resistance to 5-fluorouracil in human colon cancer xenografts by down-regulation of intratumoral thymidylate synthase.
    Fukushima M; Sakamoto K; Ohshimo H; Nakagawa F; Taguchi T
    Oncol Rep; 2010 Oct; 24(4):835-42. PubMed ID: 20811661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer.
    Hasegawa M; Miyajima A; Kosaka T; Yasumizu Y; Tanaka N; Maeda T; Shirotake S; Ide H; Kikuchi E; Oya M
    Int J Cancer; 2012 Jan; 130(2):431-42. PubMed ID: 21351099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic modulation of thymidylate synthase gene expression and fluorouracil sensitivity in human colorectal cancer cells.
    Wakasa K; Kawabata R; Nakao S; Hattori H; Taguchi K; Uchida J; Yamanaka T; Maehara Y; Fukushima M; Oda S
    PLoS One; 2015; 10(4):e0123076. PubMed ID: 25881233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.
    de la Cueva A; Ramírez de Molina A; Alvarez-Ayerza N; Ramos MA; Cebrián A; Del Pulgar TG; Lacal JC
    PLoS One; 2013; 8(6):e64961. PubMed ID: 23762272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines.
    Wada Y; Yoshida K; Suzuki T; Mizuiri H; Konishi K; Ukon K; Tanabe K; Sakata Y; Fukushima M
    Int J Cancer; 2006 Aug; 119(4):783-91. PubMed ID: 16557585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.